Drug tested for rare sunlight allergy
Disease control
Completed
This study aimed to understand how the drug afamelanotide is processed by the body in people with erythropoietic protoporphyria (EPP), a rare condition causing severe pain from sunlight. It involved 28 adolescent and adult patients. Researchers measured the drug's levels in the b…
Phase: PHASE1, PHASE2 • Sponsor: Clinuvel Europe Limited • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC